Does Clearside Biomedical, Inc. have an economic moat?

Based on its FY2024 SEC filings, the Moat Index scores Clearside Biomedical, Inc. (CLSDQ) 44.4 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 95, returns on capital 0, balance-sheet safety 55, capital discipline 24.

How has CLSDQ's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 44.4 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

Clearside Biomedical, Inc.

CLSDQ · Healthcare · $19.1M mkt cap · FY2024 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power95

Median gross margin 93.4% over 4y, very stable.

Returns on capital0

Median ROIC -136.6%, above the 9% hurdle in 0% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline24

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): —
Est. intrinsic value / share: —
Recent price: $0.25
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for CLSDQ yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale44.4 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — CLSDQ has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#180 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#178FBIO Fortress Biotech, Inc.44.6 out of 100, Shallow moatShallow moat
#179LUNG PULMONX CORPORATION44.4 out of 100, Shallow moatShallow moat
#181TMDX TransMedics Group, Inc.44.2 out of 100, Shallow moatShallow moat
#182LHX L3HARRIS TECHNOLOGIES, INC.44.1 out of 100, Shallow moatShallow moat

Compare CLSDQ with its nearest peers →All Healthcare companies on the Index →

Common questions about CLSDQ

Does Clearside Biomedical, Inc. have an economic moat?: Based on its FY2024 SEC filings, the Moat Index scores Clearside Biomedical, Inc. (CLSDQ) 44.4 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 95, returns on capital 0, balance-sheet safety 55, capital discipline 24.
How has CLSDQ's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 44.4 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows CLSDQ’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/CLSDQ"
  width="340" height="150" style="border:0"
  title="CLSDQ Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell CLSDQ. See the disclaimer.